Live Breaking News & Updates on Jens Bedke

Stay updated with breaking news from Jens bedke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Adjuvant Everolimus Falls Short in High-Risk Kidney Cancer

However, the drug did show benefit in a subgroup at highest risk of recurrence after nephrectomy ....

Noord Holland , United States , Axel Bex , Jens Bedke , Christopherw Ryan , Mike Bassett , Netherlands Cancer Institute , University College London , Stuttgart Cancer Center , Oregon Health , Science University , Knight Cancer Institute ,

ASCO GU 2023: Nivolumab plus Cabozantinib vs Sunitinib for First-Line Treatment of Advanced RCC: 3-Year Follow-up from the Phase 3 CheckMate 9ER Trial

ASCO GU 2023: Nivolumab plus Cabozantinib vs Sunitinib for First-Line Treatment of Advanced RCC: 3-Year Follow-up from the Phase 3 CheckMate 9ER Trial
urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

United States , San Francisco , Saby George , Amishi Yogesh Shah , Carlosh Barrios , Howard Gurney , Bernard Escudier , Camillo Porta , Jens Bedke , Peter Wang , Thomas Powles , Maria Teresa Bourlon , Zachary Klaassen , Viktor Fedorov , Mauricio Burotto , Yoshihiko Tomita , Martin Richardet , Christian Scheffold , Robertj Motzer , Cristina Su , Tonik Choueiri , Elizabethr Kessler , Genitourinary Gu American Society Of Clinical Oncology , Bradford Hill Clinical Research Center , Georgia Cancer Center , Augusta University Medical College Of Georgia ,

Immunotherapy Combos Up Survival in Renal Cell Carcinoma

In the absence of head-to-head trials, the findings help validate the applicability of phase 3 results to routine care. The study was published as a preprint and has not yet been peer reviewed. ....

Jens Bedke , Arnulf Stenzl , Malignant Kidney Neoplasm , Kidney Cancer , Renal Cell Cancer , Renal Cell Carcinoma , Ancer Kidney , Ancer Renal Cell , Biologic Therapy , Peer Review , Academic Medicine , Teaching Hospital , Tyrosine Kinase Inhibitor ,